3 Reasons Monsanto Company Shares Could Hit $135 in 2014

Despite the emerging threat from Dow Chemical's Enlist E3 soybeans, Monsanto's moves and strengths could push it higher this year.

Jan 24, 2014 at 12:02PM

Monsanto (NYSE:MON) may have disappointed investors recently by keeping its outlook for 2014 unchanged, but Wells Fargo isn't complaining. Impressed by the seed maker's first-quarterly earnings report, Wells Fargo upgraded its rating on the stock and upped its price target to $130-$135. That represents at least 15% upside from Monsanto's current share price of around $113.

Now that sounds pretty good, considering that rival DuPont (NYSE:DD) was also upgraded by Bank of America Merrill Lynch around the same time, but its price target represents less than 10% upside from current share price of near $64. In fact, while the consensus opinion about Monsanto points to a strong buy, most analysts consider DuPont stock a hold. So why is the Street optimistic about Monsanto? The answer could be hidden in something the company revealed in its earnings report.

Emerging trends
It was actually a soft first quarter for Monsanto, with seed and trait sales falling 5% year over year as the Latin American season drew to a close. Nevertheless, the company's net profit improved 9% on lower costs.

But two things stood out during the quarter:

  • Sales and gross profit from Monsanto's agricultural productivity segment, which sells Roundup and other herbicides, surged 23% and 50%, respectively, year over year; and
  • Soybean seed sales shot up 16% even as corn sales slipped 7%.

There are two key takeaways from this -- Monsanto's Roundup, and herbicides in general, continue to be highly demanded, and soybeans are increasingly gaining popularity among farmers. The second trend, in particular, deserves attention, given how seed companies largely depend on corn for sales and profits.

While corn accounted for roughly 63% of Monsanto's total seed sales during the first quarter, soybean seeds made up just 16% of its sales. That's not the kind of mix you would want to see given how farmers in the U.S. as well as Latin America are planting more soybeans over corn in the wake of firm soybeans crop prices. Farm Futures even projects a "major shift to soybeans" this year. Thankfully, Monsanto is ramping up its soybeans portfolio to keep up with the changing times.

Moving in the right direction
The next-generation Intacta RR2 PRO soybeans trait was among Monsanto's most important launches last year. With soybeans planting nearly over in Latin America, Monsanto is confident that Intacta has hit its targeted 3 million acres in Brazil during the season. That's huge coverage for a freshly launched product, and explains why Monsanto calls it its "largest-ever soybean launch." With Monsanto already boasting 85% share in the Brazilian soybeans market, Intacta could give any competitor sleepless nights (read: DuPont's chances of improving its 10% share in the market looks like a distant dream now).


Image source: Company website.

Meanwhile, Monsanto is readying Intacta for launch in Argentina next year, so investors can only expect things to get bigger from here. At the same time, Monsanto's Vistive Gold soybeans -- which can produce low-fat soybean oil -- and its Roundup Ready 2 Xtend soybeans will also go into testing this year. This aggressive expansion into soybeans should enable the company to stay ahead in the race, especially at a time when smaller peer Dow Chemical (NYSE:DOW) is hitting headlines for its controversial herbicide-tolerant Enlist E3 soybeans that just got a step closer to receiving the U.S. Department of Agriculture's approval.

Enlist E3 will be a major breakthrough for Dow Chemical. In fact, Dow Chemical believes that Enlist has the potential to overtake Monsanto's hugely successful Roundup Ready weed control system. While that's bad news for Monsanto, Dow Chemical has a lot of work to do because Roundup currently dominates a whopping 90% of the soybean acreage in the U.S. Moreover, it's unlikely that Monsanto will allow competition to take over so easily, so the race should only heat up from here.

There's more to cheer about

Monsanto's pipeline is anyway growing bigger by the day, with a record 29 products moving up the development ladder last year. Five of them, including Intacta RR2 PRO soybeans, are ready for commercial launch.

While that substantiates the company's leadership as an innovator, Monsanto also took a big leap in the field of precision agriculture recently by acquiring Climate Corporation. It took on $1 billion in debt to fund the acquisition, but investors should be happy to know that Monsanto is financially solid, sporting a comfortable long-term debt-to-equity ratio of 24% and having generated free cash flow of nearly $2 billion over the past 12 months. Ample reasons for investors to stay optimistic about the company.

Foolish takeaway
If the weather doesn't play truant this year, Monsanto should be headed for another good year. It projects to earn between $5.00 and $5.20 per share this year, suggesting at least 10% upside over 2013. That's good growth, and Wells Fargo may have hit the right note on this one.

How to make a killing even if the market gets crushed
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.


Fool contributor Neha Chamaria has no position in any stocks mentioned, and neither does The Motley Fool. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information